Tina Singh

Publications by Year

Research Areas

Viral gastroenteritis research and epidemiology, Tuberculosis Research and Epidemiology, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Vaccine Coverage and Hesitancy

Most-Cited Works

• → Phase 2b Controlled Trial of M72/AS01 _E Vaccine to Prevent Tuberculosis(2018)397 cited
• → Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context(2023)15 cited
• Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India.(2013)
• → Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception(2022)9 cited
• → Direct and early detection of <I>Mycobacterium tuberculosis</I> complex and rifampicin resistance from sputum smears(2013)8 cited
• → Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study(2022)6 cited
• → Heptral® (Ademetionine) in Intrahepatic Cholestasis due to Chronic Non-Alcoholic Liver Disease: Subgroup Analysis of Results of a Multicentre Observational Study in India(2014)5 cited
• → Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines(2023)5 cited
• → Heptral® (Ademetionine) in Patients with Intrahepatic Cholestasis due to Chronic Alcoholic Liver Disease: Results of a Multicentre Observational Study in Indian Patients(2014)3 cited
• → Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial(2020)3 cited